miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer

Pancancer survival analysis of cancer hallmark genes

(2021) Ádám Nagy et al.   Scientific Reports

HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth

(2020) Janika K. Liebig et al.   Cancers

Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal

(2020) Clara S. Mundry et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS

(2020) Min Jiao et al.   BIOMEDICINE & PHARMACOTHERAPY

A novel co-culture assay to assess anti-tumor CD8+ T cell cytotoxicity via luminescence and multicolor flow cytometry

(2020) Verónica Olivo Pimentel et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Regulation and modulation of antitumor immunity in pancreatic cancer

(2020) Joshua Leinwand et al.   NATURE IMMUNOLOGY

LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA

(2020) Mingwei Chen et al.   Aging-US

LncRNA XIST functions as a molecular sponge of miR-194-5p to regulate MAPK1 expression in hepatocellular carcinoma cell

(2018) Qinglei Kong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression

(2017) Yu Zhu et al.   IMMUNITY

PDL1 expression in desmoplastic melanoma is associated with tumor aggressiveness and progression

(2017) Stefan Kraft et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

LinkedOmics: analyzing multi-omics data within and across 32 cancer types

(2017) Suhas V Vasaikar et al.   NUCLEIC ACIDS RESEARCH

A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2

(2016) Shouhui Yang et al.   CANCER RESEARCH

Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer

(2016) Yaqing Zhang et al.   GUT

Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells

(2016) K E Richards et al.   ONCOGENE

Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer

(2016) Liang Li et al.   Pharmacogenetics and Genomics

Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma

(2015) V. Sandhu et al.   Molecular Oncology

Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer

(2012) Timothy R. Donahue et al.   CLINICAL CANCER RESEARCH

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Toward the blood-borne miRNome of human diseases

(2011) Andreas Keller et al.   NATURE METHODS

Posttranscriptional Upregulation by MicroRNAs

(2011) Shobha Vasudevan   Wiley Interdisciplinary Reviews-RNA

Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma

(2007) S Serba et al.   GUT